27676379|t|Postprandial anti-hyperglycemic activity of marine Streptomyces coelicoflavus SRBVIT13 mediated gold nanoparticles in streptozotocin induced diabetic male albino Wister rats
27676379|a|The present study focuses on the biosynthesis of gold nanoparticles (AuNPs) using Streptomyces coelicoflavus (S. coelicoflavus) SRBVIT13 isolated from marine salt pan soils collected from Ongole, Andhra Pradesh, India. The biosynthesised AuNPs are characterised by UV-visible spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy, high-resolution transmission electron microscopy and energy-dispersive X-ray analysis. Transmission electron microscopy study suggests that the biosynthesised AuNPs are spherical in shape within a size range of 12-20 nm (mean diameter as 14 nm). The anti-type II diabetes activity of AuNPs is carried out by testing it in vitro α-glucosidase and α-amylase enzyme inhibition activity and in vivo postprandial anti-hyperglycemic activity in sucrose and glucose -loaded streptozotocin induced diabetic albino Wister rats. AuNPs has shown a significant inhibitory activity of 84.70 and 87.82% with IC50 values of 67.65 and 65.59 μg/mL to α-glucosidase and α-amylase enzymes, while the diabetic rats have shown significant reduction in the post postprandial blood glucose level by 57.80 and 88.09%, respectively compared with control group after AuNPs treatment at the concentration of 300 and 600 mg/kg body weight. Hence, this biosynthesised AuNPs might be useful in combating type II diabetes mellitus for the betterment of human life.
27676379	13	40	anti-hyperglycemic activity	T033	UMLS:C2825141
27676379	51	86	Streptomyces coelicoflavus SRBVIT13	T007	UMLS:C1656173
27676379	96	100	gold	T103	UMLS:C0018026
27676379	118	132	streptozotocin	T103	UMLS:C0038432
27676379	141	149	diabetic	T038	UMLS:C0011847
27676379	155	173	albino Wister rats	T204	UMLS:C0034716
27676379	223	227	gold	T103	UMLS:C0018026
27676379	256	310	Streptomyces coelicoflavus (S. coelicoflavus) SRBVIT13	T007	UMLS:C1656173
27676379	386	391	India	T082	UMLS:C0021201
27676379	422	435	characterised	T062	UMLS:C1881968
27676379	439	462	UV-visible spectroscopy	T058	UMLS:C0037812
27676379	464	481	X-ray diffraction	T058	UMLS:C0043301
27676379	483	522	Fourier transform infrared spectroscopy	T062	UMLS:C0206055
27676379	524	572	high-resolution transmission electron microscopy	T058	UMLS:C2697588
27676379	611	643	Transmission electron microscopy	T058	UMLS:C0678118
27676379	693	711	spherical in shape	T082	UMLS:C0332501
27676379	721	725	size	T082	UMLS:C0456389
27676379	774	804	anti-type II diabetes activity	T033	UMLS:C2825141
27676379	852	865	α-glucosidase	T103	UMLS:C0002272
27676379	870	879	α-amylase	T103	UMLS:C3853624
27676379	880	906	enzyme inhibition activity	T038	UMLS:C2248397
27676379	911	918	in vivo	T082	UMLS:C1515655
27676379	932	959	anti-hyperglycemic activity	T033	UMLS:C2825141
27676379	963	970	sucrose	T103	UMLS:C0038636
27676379	975	982	glucose	T103	UMLS:C0017725
27676379	991	1005	streptozotocin	T103	UMLS:C0038432
27676379	1014	1022	diabetic	T038	UMLS:C0011847
27676379	1023	1041	albino Wister rats	T204	UMLS:C0034716
27676379	1073	1092	inhibitory activity	T038	UMLS:C2248397
27676379	1158	1171	α-glucosidase	T103	UMLS:C0002272
27676379	1176	1185	α-amylase	T103	UMLS:C3853624
27676379	1186	1193	enzymes	T103	UMLS:C0014442
27676379	1205	1213	diabetic	T038	UMLS:C0011847
27676379	1214	1218	rats	T204	UMLS:C0034693
27676379	1277	1296	blood glucose level	T033	UMLS:C0428554
27676379	1498	1523	type II diabetes mellitus	T038	UMLS:C0011860
27676379	1546	1551	human	T204	UMLS:C0086418